Trump Makes New Prediction
WASHINGTON, D.C. — In a bold move to protect American seniors and taxpayers, President Donald Trump has unveiled a sweeping executive order aimed at slashing prescription drug prices. The policy, which enforces “Most Favored Nation” pricing, could cause the cost of medications in the United States to fall by as much as 89%, according to the President.
“You’ll see drug prices drop like a rock,” Trump declared. “The savings for our country—and for our seniors—will be beyond calculation.”
America First: Ending Global Drug Price Discrimination
For decades, Americans—especially seniors on Medicare and Medicaid—have paid the highest prescription drug prices in the world. Under Trump’s executive order, that era may finally come to an end.
The policy mandates that the U.S. will no longer pay more for prescription drugs than the lowest price paid by any other developed country. This “Most Favored Nation” clause effectively flips the global pricing model—putting America First and putting Big Pharma on notice.
“Other countries have been taking advantage of us for years,” Trump said. “We’re not going to let them rip off our taxpayers anymore.”
Massive Savings for Seniors and Taxpayers
This policy is expected to bring massive cost reductions for retirees, veterans, and everyday Americans. Trump noted that even the “worst-case savings” scenario would result in a 50% price drop, with up to 89% in many cases.
The changes will directly benefit:
- Seniors on Medicare Part D
- Medicaid recipients
- Retired veterans relying on government healthcare
- American families struggling with out-of-pocket drug costs
Strong Action from the Trump Administration
Trump has ordered Health and Human Services Secretary Robert F. Kennedy Jr. to deliver a full plan within 30 days. If pharmaceutical companies refuse to cooperate, the federal government will impose the new pricing by executive authority.
Speaking to Kennedy and Centers for Medicare and Medicaid Services (CMS) Administrator Mehmet Oz, Trump made his expectations clear:
“If you don’t get this done, you’re fired.”
Big Pharma Pushes Back—But Trump Stands Firm
As expected, powerful pharmaceutical lobbyists and global corporations are already resisting the plan. The Biotechnology Innovation Organization (BIO)—a lobbying group for drug manufacturers—has called the move “dangerous,” claiming it could harm innovation.
But Trump’s team is standing strong.
“This isn’t about corporate profits,” Trump said. “This is about protecting American patients, seniors, and taxpayers.”
What It Means for You: Lower Drug Prices Are Coming
With drug prices set to fall dramatically, Americans across the country—especially older voters—are watching closely. The executive order is part of Trump’s broader Make America Healthy Again agenda, promising to restore affordability and accountability to U.S. healthcare.
Bottom line: If successful, this initiative could deliver historic savings for millions of Americans.
Stay tuned for updates on how this policy could lower your out-of-pocket drug costs.
